SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 million in US IPO

-Biopharmaceutical firm Neumora Therapeutics, backed by Amgen and Japan's SoftBank, is aiming to raise up to $264.8 million in its U.S. initial public offering, according to a regulatory filing on...
-Today at 06:29 am- MarketScreener

Related Keywords

Bengaluru ,Karnataka ,India ,United States ,Ukraine ,Russia ,America ,Shounak Dasgupta ,Pritam Biswas ,Saumyadeb Chakrabarty ,Softbank ,Massachusetts Based Neumora ,Markets ,